Micro-RNA Expression Profiles in Localised Prostate Cancer

Withdrawn

• Conditions: Prostate Cancer; Radical Prostatectomy

• Registration Number: NCT03338712
• Lead Sponsor: Wuerzburg University Hospital

Brief Summary

Recurrence free survival The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-02-01
• Primary Completion: 2016-04-01
• Study Completion: 2016-04-01
• Status Verified: 2017-11
• Study First Submitted: 2017-11-02
• Study First Submitted QC: 2017-11-06
• Study First Posted: 2017-11-09
• Last Update Submitted: 2023-12-05
• Last Update Posted: 2023-12-12

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

• 35 Years to 80 Years
• Male
• Patients with clinically localised high risk prostate cancer

Exclusion Criteria

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence free survival	Up to 120 months. From date of inclusion until date of death from any cause	The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association.

Secondary Outcome Measures

Name	Time	Method
Cancer specific survival	Up to 120 months. From date of inclusion until date of death from any cause	Cancer specific survival